Key result
Type 2 diabetes cuts cardiac mitochondrial ATP synthase subunits by ~50% in mice.
Why the study?
Mitochondrial dysfunction plays a key role in the pathogenesis of diabetic cardiomyopathy, motivating investigation into the structural and functional changes of heart muscle mitochondria in diabetes mellitus.
Does type 2 diabetes cause structural and functional impairments in cardiac mitochondria compared to intact controls in a mouse model?
Does type 2 diabetes cause structural and functional impairments in cardiac mitochondria compared to intact controls in a mouse model?
This preclinical study demonstrates that diabetic cardiomyopathy in type 2 diabetic mice involves complex mitochondrial dysfunction, including 42-52% reductions in key ATP synthase subunits, quality control dysregulation, and increased sensitivity to mPTP opening.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ATP synthase impairment in diabetic cardiomyopathy; requires human studies before clinical relevance.
Diabetes mellitus is closely associated with the development of diabetic cardiomyopathy (DCM), in the pathogenesis of which mitochondrial dysfunction plays a key role. The aim of this work was to study the structural and functional changes of mitochondria in the heart muscle in diabetes mellitus in order to understand their role in the development of diabetic cardiomyopathy. The functional and structural characteristics of mouse heart mitochondria in conditions of type 2 diabetes were evaluated. The study was performed on mice with type 2 diabetes (line C57BL/KsJ-db/db) and intact animals (C57BL/6J) as a control. Respiratory depression, acceleration of Ca2+-induced mitochondrial swelling, selective decrease in levels of the main subunits of respiratory chain complexes (OXPHOS), decrease in the content of ATP synthase subunits (ATPB, by 42%; ATP5F1, by 48%, and ATP5G1, by 52%) and its activity, increased levels of translocator protein (TSPO), cyclophilin D (CyP-D) and voltage-dependent anion channel 1 (VDAC1) with a decrease in the content of prohibitin 2 (PHB2) and superoxide dismutase (Mn-SOD2) were revealed. It has been shown that diabetic cardiomyopathy is based on complex mitochondrial dysfunction, including structural damage to the respiratory chain, impaired ATP synthase activity, dysregulation of the mitochondrial quality control system, and increased sensitivity to the opening of the non-specific permeability transition pore (mPTP). The data obtained reveal new pathogenetic mechanisms of DCM and highlight potential targets for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Baburina et al. (2026) studied Type 2 diabetes mellitus and diabetic cardiomyopathy. Type 2 diabetes (C57BL/KsJ-db/db genotype) vs. Intact non-diabetic control mice (C57BL/6J) was evaluated on Functional and structural characteristics of mouse heart mitochondria, including ATP synthase subunit content (ATPB, ATP5F1, ATP5G1) and activity. Type 2 diabetes in db/db mice decreased cardiac mitochondrial ATP synthase subunits ATPB by 42%, ATP5F1 by 48%, and ATP5G1 by 52% versus controls.
Synapse has enriched 10 related papers. Consider them for comparative context: